BackCollegium Pharmaceutical Overview

Collegium Pharmaceutical Operating Income

Operating Income for COLL.

Quarterly Operating Income

$31.96M
↑ 47.39% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$188.38M
↑ 32.56% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin